We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

MVCT Imaging Pilot Study Using Helical Tomotherapy

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00168142
First Posted: September 15, 2005
Last Update Posted: February 24, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Cross Cancer Institute
Information provided by (Responsible Party):
AHS Cancer Control Alberta
  Purpose
To compare the two types of scans, the conventional CT planning scan and the tomotherapy planing scan.

Condition
Cancer, Carcinoma

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: MVCT Imaging Pilot Study Using Helical Tomotherapy

Resource links provided by NLM:


Further study details as provided by AHS Cancer Control Alberta:

Enrollment: 16
Study Start Date: October 2003
Study Completion Date: August 2009
Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
primary care clinic
Criteria

Inclusion Criteria:

  • Undergoing radiotherapy metallic artifact in radiation field.

Exclusion Criteria:

  • Contraindication to radiotherapy
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00168142


Locations
Canada, Alberta
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2
Sponsors and Collaborators
AHS Cancer Control Alberta
Cross Cancer Institute
Investigators
Principal Investigator: Rufus Scrimger, MD AHS Cancer Control Alberta
  More Information

Responsible Party: AHS Cancer Control Alberta
ClinicalTrials.gov Identifier: NCT00168142     History of Changes
Other Study ID Numbers: 21131
First Submitted: September 9, 2005
First Posted: September 15, 2005
Last Update Posted: February 24, 2016
Last Verified: December 2011

Keywords provided by AHS Cancer Control Alberta:
Helical tomotherapy
Megavoltage imaging